©2024 Stanford Medicine
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy
Not Recruiting
Trial ID: NCT03802214
Purpose
A case-control study to evaluate the immunoinflammatory effect of prior exposure to anti-TNF
therapy in patients with ulcerative colitis starting vedolizumab therapy
Official Title
A Case-control Study to Evaluate the Immunoinflammatory Effect of Prior Exposure to Anti-TNF Therapy in Patients With Ulcerative Colitis Starting Vedolizumab Therapy
Eligibility
Inclusion Criteria:
- adult patients (>18 years old)
- clinical diagnosis of inflammatory bowel disease (Ulcerative Colitis)
- clinical indication for biologic therapy
- naive or failed anti-TNF therapy previously
Exclusion Criteria:
- patients allergic or intolerant to vedolizumab,
- past use of vedolizumab;
- patient unable to give consent to enter the study
Intervention(s):
drug: Vedolizumab
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
John Gubatan, MD
650-736-5555